文献速递临床试验与 GCP流行病学与生物统计

脑氧饱和度监测指导机械通气新生儿的治疗:SafeBoosC-IIIv随机临床试验第一步的统计分析计划

Treatment guided by cerebral oximetry in mechanically ventilated newborns: a statistical analysis plan for step one of the SafeBoosC-IIIv randomised clinical trial.
PubMed 文献 · Trials · 2025-12-18

SafeBoosC-IIIv试验为多中心平行组随机临床试验,分两步进行。本文为第一步的统计分析计划,旨在评估脑氧饱和度监测指导治疗对比常规护理能否增加有创机械通气新生儿的无住院天数,计划随机1610例,主要结局为随机化后90天内无住院天数。

要点

  • 纳入胎龄≥28+0周、生后不足28天、预计有创机械通气至少24小时的新生儿。
  • 随机化后90天内无住院天数为主要结局,按中心分层采用van Elteren检验分析。
  • 分析遵循意向性治疗原则,由两名统计师独立完成,计划随机1610例。

核心结论

  • 本统计分析计划详细描述了SafeBoosC-IIIv试验第一步的计划统计分析。

研究设计与样本

  • SafeBoosC-IIIv试验为多中心、平行组、随机临床试验,分两步进行,本文为第一步的统计分析计划。
  • 计划随机1610名参与者,按1:1分配至脑氧饱和度监测指导治疗组或常规护理组。
  • 纳入标准为胎龄≥28+0周、生后日龄小于28天、预计需要有创机械通气(插管)至少24小时,且具备脑氧饱和度监测仪可在开始有创机械通气后6小时内启动监测。
  • 排除标准为疑似或确诊脑损伤或可能需手术的先天性心脏畸形。

主要发现

  • 主要结局为随机化后90天内的无住院天数。
  • 主要结局将按中心分层采用van Elteren检验进行分析。
  • 统计分析计划详细描述了计划的分析,包括缺失数据处理方法和统计假设评估方法。

关键数值与推荐

  • 主要结局采用van Elteren检验按中心分层分析。
  • 分析遵循意向性治疗原则,由两名统计师独立进行。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Newborns requiring invasive mechanical ventilation are at high risk of neurodevelopmental impairment, prolonged hospitalisation, and increased mortality. Treatment guided by cerebral oximetry monitoring has been proposed to reduce morbidity and mortality. METHODS: The SafeBoosC-IIIv trial is a multicentre, parallel-group, randomised clinical trial. The trial will be conducted in two steps. This is a statistical analysis plan for step one. The objective of step one is to assess whether treatment guided by cerebral oximetry monitoring, compared with usual care, increases the number of hospital-free days in newborns receiving invasive mechanical ventilation. Inclusion criteria are gestational age ≥ 28 + 0 weeks, postnatal age less than 28 days, expected to receive invasive mechanical ventilation (intubation) for at least 24 h, and a cerebral oximeter available so monitoring can be started within 6 h after initiation of invasive mechanical ventilation. Exclusion criteria are suspicion of or confirmed brain injury or congenital heart malformation likely to require surgery. A total of 1610 participants will be randomised 1:1 to treatment guided by cerebral oximetry monitoring or usual care. The primary outcome will be hospital-free days within 90 days of randomisation, which will be analysed with the van Elteren test stratified by 'centre'. This statistical analysis plan provides a detailed description of the planned analyses, including methods for handling missing data and assessing statistical assumptions. Analyses will follow the intention-to-treat principle and will be performed independently by two statisticians. CONCLUSION: This statistical analysis plan describes the planned statistical analyses in detail for step one of the SafeBoosC-IIIv trial. TRIAL REGISTRATION: ClinicalTrials.gov NCT05907317. First submitted on 8 June 2023, https://clinicaltrials.gov/study/NCT05907317 .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Petersen JJ, Kamp CB, Olsen MH, et al. Treatment guided by cerebral oximetry in mechanically ventilated newborns: a statistical analysis plan for step one of the SafeBoosC-IIIv randomised clinical trial. Trials. 2025. PMID: 41413912. doi:10.1186/s13063-025-09387-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。